Table 3.

Patient reported outcomes using mean health-related quality of life scores

SF-36OctreotidePlacebo
Physical functioning
    time 074.8 (21.96)80.4 (23.73)
    12 mo77.0 (21.32)82.1 (18.58)
    P0.40130.5668
Physical role
    time 059.8 (42.13)76.8 (39.79)
    12 mo74.1 (35.00)75.0 (41.60)
    P0.0381a0.8555
Bodily pain
    time 067.8 (15.29)65.5 (24.25)
    12 mo75.7 (19.02)68.7 (25.51)
    P0.0158a0.4653
General health
    time 055.9 (21.29)58.0 (23.63)
    12 mo53.5 (17.32)63.4 (23.96)
    P0.52650.1975
Vitality
    time 049.6 (21.81)53.9 (25.96)
    12 mo54.4 (24.23)54.6 (27.91)
    P0.24140.7801
Social functioning
    time 079.0 (19.56)75.0 (27.30)
    12 mo82.9 (19.35)81.3 (21.79)
    P0.26530.1309
Role emotional
    time 082.1 (32.05)73.8 (37.39)
    12 mo91.4 (23.74)81.0 (38.60)
    P0.25570.4874
Mental health
    time 076.0 (14.12)75.4 (18.75)
    12 mo76.9 (16.54)80.7 (18.76)
    P0.87340.2030
Standardized physical component scale
    time 042.6 (9.73)46.0 (10.16)
    12 mo44.7 (10.00)46.1 (9.51)
    P0.05630.9235
Standardized mental component scale
    time 050.8 (7.74)48.4 (10.96)
    12 mo52.2 (8.03)51.3 (11.15)
    P0.50490.0738
  • Data are mean (SD). Scored on a range of 0 to 100 (0 = worst imaginable, 100 = best imaginable). P (paired t test).

  • aP < 0.05 within group.